Check back soon for new upcoming events!
Previously Recorded Events
Health Sector Leaders Consortium (September 20, 2022)
This inaugural event brought together industry leaders who are disrupting the status quo of business in healthcare. Watch the recordings to learn more about how industry trends, innovation, and cross-sector engagement are driving solutions to address value, access, and health equity. Presenters included Andy McMahon (Vice President, Community Investment & Innovation, UnitedHealthcare Community & State), Grady Davis (Vice President, Global Commercial Marketing Structural Heart, Medtronic), Sarah Taylor (Vice President & Chief Analytics Officer, Prime Therapeutics), Frank Jaskulke (Vice President of Intelligence, Medical Alley Association), Mark Steffen (Senior Vice President & Chief Medical Officer, Blue Cross and Blue Shield of Minnesota), Sami Yusuf (Vice Chair of Corporate Development, Mayo Clinic International), and was moderated by BACH Founding Director Prof. Pinar Karaca-Mandic.
Health Sector Leaders Consortium - Part 1 - featuring Andy McMahon, Grady Davis, and Sarah Taylor
Health Sector Leaders Consortium - Part 2 - featuring Frank Jaskulke, Mark Steffen, and Sami Yusuf
This discussion, led by BACH Founding Director Prof. Pinar Karaca-Mandic, reviewed recent legal and policy questions under discussion in the Courts and Congress and examined how stakeholders are responding to the ever-evolving 340B program landscape. Presenters included Thomas Barker, JD (Foley Hoag, LLP); Sayah Nikpay, PhD (University of Minnesota School of Public Health); and Faraz Siddiqui, JD, MPH (Hyman, Phelps & McNamara).
Convene Conference: Consumerization of Healthcare & Digital Health (April 26, 2022)
CONVENE is a thought-leadership conference focused on the intersection of healthcare, technology, and data analytics as major solutions to healthcare issues. The 4th annual Convene explored consumerism in healthcare and the evolution of digital health innovations to support personalized care. Leaders from the patient, provider, payer, medical device, and regulatory sectors addressed how their organizations are transforming the medical industry to increase access and improve the quality of care.
The University of Minnesota hosted the 3rd annual Health Data Competition promoting interdisciplinary collaboration using data to address current healthcare challenges. Student teams analyzed the Hospital Consumer Assessment of Healthcare Provider & Systems (HCAHPS) survey to assess how patient experience in a hospital setting impacts other aspects of care.
The University of Minnesota research team partnered with the Minnesota Hospital Association to introduce their new study "Social Bonds as a Pooled Financing Mechanism to Address Social Drivers of Health Equity." The study, led by BACH Founding Director Prof. Pinar Karaca-Mandic, investigates if a novel social bond can pool resources across multiple competing health plans to create stable, long-term financing for interventions addressing social determinants of health and promoting racial justice and health equity.
MILI Academic Director, Prof. Pinar Karaca-Mandic and MILI Executive in Residence, Gopal Khanna talk with Dr. Meena Seshamani, the newly appointed Director for the Center for Medicare, on her vision for the future of Medicare, and the challenges and opportunities the industry faces in the post-pandemic era of health.
The Landscape of Nonprofit Health Plans in Minnesota (November 10, 2021)
Lucas Nesse, (President & CEO, MCHP), Andrea Walsh (President & CEO, HealthPartners), and John Naylor (President & CEO, Medica) discussed the landscape of nonprofit health plans in Minnesota, the impact of nonprofit health plans, industry trends, and the employment outlook.
The Changing Market of Biosimilars (October 13, 2021)
Biologics have revolutionized the treatment of care, but often at high prices. As the biosimilar market evolves with new biosimilars coming to market, it is essential to consider patient, provider, payer, manufacturer, and policy dynamics that influence uptake and affordability. This virtual panel discussion, led by BACH Founding Director and Prime Therapeutics leadership, introduces the biosimilars landscape and discusses coverage and pricing of biosimilars, provider-level factors influencing uptake, legislative challenges, and manufacturer perspectives.